Mr. Andre Jerome reports

AURORA IGNITES GLOBAL EXPANSION WITH WHISTLER CANNABIS CO. BRAND DEBUT IN AUSTRALIA

Aurora Cannabis Inc. has launched Whistler Cannabis Co. in Australia. As one of Canada's original cannabis brands, with a proud history of growing premium, indoor craft cannabis, this unique brand offers Australian patients a true Canadian cannabis experience.

"Whistler is a tried-and-true brand in the Canadian market," said Andre Jerome, executive vice-president of global business development at Aurora. "We're excited to now extend its legacy and our Canadian cultivation expertise to Australian patients. This milestone underscores our commitment to global growth and our patient-first approach."

First developed in 2013, Whistler is cultivated in Aurora's state-of-the-art facility, Aurora Alpine, located in Pemberton Valley in British Columbia. Produced in small batches using top-tier, proprietary genetics, each plant is harvested at its peak, ensuring consistent quality. The premium craft medical cannabis flower is hang dried and hand trimmed, undergoing a slow, controlled drying process to preserve delicate trichomes -- which contain most of the plant's aroma, cannabinoids and active compounds.

The first two Whistler Cannabis products to launch in Australia are:

• Ginger Breath -- 32 per cent THC (tetrahydrocannabinol), indica, 10 grams, bred from '91 Royale and Driftwood Diesel genetics, and has a terpene profile of caryophyllene, pinene and linalool. This cultivar has a complex aroma profile of spicy ginger, gasoline, chai and citrus;
• Critical Diesel -- 28 per cent THC, sativa, 10 grams, bred from Critical Sensi Star and Driftwood Diesel lineages, and has a terpene profile of caryophyllene, pinene and myrcene. This cultivar has a fruity aroma profile of cherry, grape, strawberry, vanilla and gasoline.

Aurora has established trusted leadership in Canadian and international medical cannabis markets through robust regulatory expertise, investment in technology and distribution, and an unwavering commitment to science. A strict adherence to European Union (EU) and Therapeutics Goods Administration (TGA) GMP (good manufacturing practices) certified production enables the company's success in international markets.

About Aurora Cannabis Inc.

Aurora is opening the world to cannabis, serving both the medical and consumer markets across Canada, Europe, Australia and New Zealand. Headquartered in Edmonton, Alta., Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co., as well as international brands Pedanios, IndiMed and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd., North America's leading supplier of propagated agricultural plants. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, wellness and adult recreational markets wherever they are launched.

Aurora's common shares trade on the Nasdaq Stock Market and Toronto Stock Exchange under the symbol ACB.

We seek Safe Harbor.